Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Hair loss requires customized treatments based on its various causes and types.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

The document concludes that doctors should thoroughly check postmenopausal women with sudden increased male traits for rare conditions like androgen-producing endometrial cancer.

Fermented papaya and mangosteen in hair care products helped prevent hair loss and improve hair thickness.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Finasteride can slow hair loss and promote growth in postmenopausal women.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Growth factors and microneedle therapy increase hair density in women with hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Stem cells can effectively regrow hair in women with hair loss.

Hair loss in men is common, treatable, but not curable.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

No cure for female pattern hair loss, but various effective treatments exist.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.